...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: coldn brought this up on the rvx board...
Reply New Message
Prev Message Back To Forum Threaded View Next Message

One clarification I should make is that I erroneously get in a habit of talking of the two companies as one management and Board while the Boards are much different. I should ihave said, "if Zenith carries through as they have posed to us in the past" rather than RVX. Sorry!

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply